UPDATED -- Benitec Biopharma Releases First Quarter 2027 Fiscal-Year Financial Results and Provides Operational Update
Positive interim clinical results from the ongoing BB-301 Phase 1b/2a study for dysphagic patients w
Positive interim clinical results from the ongoing BB-301 Phase 1b/2a study for dysphagic patients w